|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute of Neurological Disorders and Stroke (NINDS) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00030940 |
Purpose
This study will explore the role of various immune factors involved in producing the disease symptoms in stiff-person syndrome (SPS) and follow disease progression in patients. SPS is a progressive disease in which unexpected noises, touches or stressful events set off muscle spasms and stiffness. It is thought to be an autoimmune disease in which the body produces antibodies that attack certain healthy tissues. A better understanding of the disease may help researchers design new therapies.
Patients of any age with SPS may be eligible for this study, except those who:
Candidates will be screened with a medical history and physical and neurological examinations to confirm the diagnosis of SPS.
After screening, those enrolled in the study will be followed at the NIH Clinical Center every 6 months for 2 years (months 6, 12, 18, and 24) to have the following tests and procedures:
| Condition |
|---|
|
Stiff-Person Syndrome |
| Study Type: | Observational |
| Official Title: | Natural History and Immunopathogenesis of Stiff Person Syndrome (SPS) |
| Estimated Enrollment: | 40 |
| Study Start Date: | February 2002 |
| Estimated Study Completion Date: | December 2007 |
Stiff-person syndrome (SPS) is a progressive neurological disorder characterized by stiffness of the trunk or limb muscles and frequent muscle spasms induced by unexpected visual, auditory, or somatosensory stimuli. It is an incapacitating disorder that leads to recurrent falls and impaired ambulation. The cause of the disease is unknown but an autoimmune pathogenesis is implicated based on its association with other autoimmune diseases and auto-antibodies, specific HLA haplotypes and high titer antibodies against GAD, the rate-limiting enzyme for the synthesis of GABA. Understanding the autoimmune mechanisms of SPS is fundamental to refine the diagnostic criteria and develop specific therapies. The goals of this study are: a) define the natural history of SPS in a homogeneous cohort of patients, b) explore a pathogenetic link between SPS and viral infections based on the known peptide homology between GAD and certain viruses and c) establish GAD-specific T-cell clones and search for candidate antigenic epitopes using synthetic peptide libraries. Collected clinical data will be used to delineate the rate of disease progression and the frequency of association with other autoimmune illnesses, auto-antibodies, or malignancies. It is anticipated that the knowledge acquired from the study will help us understand the mechanism of the disease and design antigen-specific therapeutic strategies. This is an investigative study intended to define the natural history and pathogenesis of SPS. No new therapy will be provided except of standard care.
Eligibility| Ages Eligible for Study: | 25 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
All patients who fulfill the recently revised clinical criteria for SPS.
EXCLUSION CRITERIA:
Lack of anti-GAD antibodies in the serum;
Very advanced disease state that precludes traveling;
Severe cardiovascular, renal, or other end-organ-disease states.
Contacts and Locations| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | |
| Bethesda, Maryland, United States, 20892 | |
| United States, Pennsylvania | |
| Thomas Jefferson University | |
| Philadelphia, Pennsylvania, United States, 19107-6541 | |
More Information
| Study ID Numbers: | 020122, 02-N-0122 |
| Study First Received: | February 14, 2002 |
| Last Updated: | March 5, 2008 |
| ClinicalTrials.gov Identifier: | NCT00030940 History of Changes |
| Health Authority: | United States: Federal Government |
|
Antigenic Epitopes Glutamic Acid Decarboxylase (GAD) Auto-antibodies Stiffness Index SPS |
Anti-GAD MR Spectroscopy GAD Stiff Person Syndrome SPS |
|
Stiff-Person Syndrome Autoimmune Diseases Pathologic Processes Disease Immune System Diseases Neuromuscular Diseases |
Spinal Cord Diseases Syndrome Nervous System Diseases Central Nervous System Diseases Autoimmune Diseases of the Nervous System |